共 15 条
[5]
Oxycodone combined with opioid receptor antagonists: efficacy and safety[J] . Mellar Davis,Harold W Goforth,Pam Gamier.Expert Opinion on Drug Safety . 2013 (3)
[6]
Buprenorphine and buprenorphine/naloxone soluble-film for treatment of opioid dependence
[J].
EXPERT OPINION ON DRUG DELIVERY,
2012, 9 (11)
:1409-1417
Soyka, Michael
.
[7]
A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence[J] . N. Lintzeris,S.Y. Leung,A.J. Dunlop,B. Larance,N. White,G.R. Rivas,R.M. Holland,L. Degenhardt,P. Muhleisen,M. Hurley,R. Ali.Drug and Alcohol Dependence . 2012
[8]
Morphine sulfate and naltrexone hydrochloride extended release capsules for the management of chronic, moderate-to-severe pain, while reducing morphine-induced subjective effects upon tampering by crushing[J] . Howard S Smith.Expert Opinion on Pharmacotherapy . 2011 (7)
[9]
Relative oral bioavailability of morphine and naltrexone derived from crushed morphine sulfate and naltrexone hydrochloride extended-release capsules versus intact product and versus naltrexone solution: A single-dose, randomized-sequence, open-label, three-way crossover trial in healthy volunteers[J] . Franklin K. Johnson,Jeffrey G. Stark,Frederick A. Bieberdorf,Joe Stauffer.Clinical Therapeutics . 2010 (6)
[10]
Single- and Multiple-Dose Pharmacokinetic Evaluation of Oxycodone and Naloxone in an Opioid Agonist/Antagonist Prolonged-Release Combination in Healthy Adult Volunteers
[J].
CLINICAL THERAPEUTICS,
2008, 30 (11)
:2051-2068
Smith, Kevin
;
Hopp, Michael
;
Mundin, Gill
;
Leyendecker, Petra
;
Bailey, Paul
;
Grothe, Birgit
;
Uhl, Reiner
;
Reimer, Karen
.